Risk of acute leukemia following adjuvant epirubicin-based adjuvant chemotherapy for breast cancer.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2001
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)